The effect of exposure to radiofrequency fields on cancer risk in the general and working population: A protocol for a systematic review of human observational studies
Autor: | Maria Blettner, Martin Röösli, Ken Karipidis, Susanna Lagorio, Dan Baaken, Maria Feychting, Mark Elwood, Marília Silva Paulo, Nicola Orsini, Tom Loney |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Adult
medicine.medical_specialty Epidemiology Radio Waves MEDLINE Base stations Case-control studies Pituitary tumours Brain cancer Radiofrequency electromagnetic fields Article Electromagnetic Fields Meta-Analysis as Topic Neoplasms medicine Salivary gland tumours Leukaemia Humans Medical physics Mobile phones GE1-350 Internal validity Broadcast transmitters Child Microwaves General Environmental Science business.industry Brain Neoplasms Acoustic neuroma Case-control study Childhood leukaemia Environmental exposure Glioma Environmental Exposure Occupational exposure Environmental sciences Systematic review protocol Cohort Cordless phones Cohort studies Observational study business Meningioma Cell Phone Cohort study |
Zdroj: | Environment International, Vol 157, Iss, Pp 106828-(2021) Environment International |
ISSN: | 0160-4120 |
Popis: | Highlights • RF-EMF was classified by IARC as possibly carcinogenic to humans (2B) in May 2011 • A systematic review of all subject-relevant epidemiological studies is now needed. • A detailed protocol ensures the review's transparency, utility and credibility. • Original study validity will be evaluated with a customized OHAT risk of bias tool. • Internal coherence and external plausibility will inform conclusions. Background The World Health Organization (WHO) has an ongoing project to assess potential health effects of exposure to radiofrequency electromagnetic fields (RF-EMF) in the general and working population. Here we present the protocol for a systematic review of the scientific literature on cancer hazards from exposure to RF-EMF in humans, commissioned by the WHO as part of that project. Objective To assess the quality and strength of the evidence provided by human observational studies for a causal association between exposure to RF-EMF and risk of neoplastic diseases. Eligibility criteria We will include cohort and case-control studies investigating neoplasia risks in relation to three types of exposure to RF-EMF: near-field, head-localized, exposure from wireless phone use (SR-A); far-field, whole body, environmental exposure from fixed-site transmitters (SR-B); near/far-field occupational exposures from use of handheld transceivers or RF-emitting equipment in the workplace (SR-C). While no restriction on tumour type will be applied, we will focus on selected neoplasms of the central nervous system (brain, meninges, pituitary gland, acoustic nerve) and salivary gland tumours (SR-A); brain tumours and leukaemias (SR-B, SR-C). Information sources Eligible studies will be identified through Medline, Embase, and EMF-Portal. Risk-of-bias assessment We will use a tailored version of the OHAT's tool to evaluate the study's internal validity. Data synthesis We will consider separately studies on different tumours, neoplasm-specific risks from different exposure sources, and a given exposure-outcome pair in adults and children. When a quantitative synthesis of findings can be envisaged, the main aims of the meta-analysis will be to assess the strength of association and the shape of the exposure–response relationship; to quantify the degree of heterogeneity across studies; and explore the sources of inconsistency (if any). When a meta-analysis is judged inappropriate, we will perform a narrative synthesis, complemented by a structured tabulation of results and appropriate visual displays. Evidence assessment Confidence in evidence will be assessed in line with the GRADE approach. Funding This project is supported by the World Health Organization. Co-financing was provided by the New Zealand Ministry of Health; the Istituto Superiore di Sanità in its capacity as a WHO Collaborating Centre for Radiation and Health; ARPANSA as a WHO Collaborating Centre for Radiation Protection. Registration PROSPERO CRD42021236798. |
Databáze: | OpenAIRE |
Externí odkaz: |